Alex Nikitine
Dr. iur., LL.M., Attorney at Law
Partner

Alex Nikitine Alex Nikitine Alex Nikitine Alex Nikitine


Alex Nikitine's practice focuses on domestic and international M&A transactions, public tender offers, IPOs and other public (ECM/DCM) offerings, private equity and venture capital transactions, corporate governance and general corporate, stock exchange and capital markets laws. His experience for the last 15 years includes numerous transactions in these areas of expertise, in particular with companies in the Life Sciences, Banking or E-Commerce industry.

Alex Nikitine has been recommended by several international directories such as Chambers, IFLR1000 and The Legal 500 as a leading lawyer (by Chambers Global/Europe in both Corporate/M&A and Capital Markets). He is considered "knowledgeable and quick" and "very active and likeable" and is being appreciated by his "high level of client orientation" (The Legal 500; Chambers).

Alex Nikitine represents clients in proceedings before the SIX Swiss Exchange, the Swiss Takeover Board (UEK) and the Swiss financial market supervisory authority FINMA. He is a member of the board of examiners for the Swiss certified tax expert exams and a SIX Swiss Exchange recognised representative under art. 43 Listing Rules. He regularly publishes and speaks at conferences in his areas of expertise.

Alex Nikitine studied law at the University of Basel (lic. iur., 2000) and Harvard Law School (LL.M., 2004) and he received a doctorate (PhD; on Swiss and US securities laws) from the University of Zurich (Dr. iur., 2007). In 2009, he worked at Davis Polk & Wardwell LLP in New York, USA.

Alex Nikitine speaks German and English. He is registered with the Zurich Bar Registry and is admitted to practice in Switzerland as well as in the state of New York, USA.

Contact
Alex Nikitine
Direct phone: +41 58 658 56 32


Walder Wyss Ltd.
Seefeldstrasse 123
P.O. Box
8034 Zurich
Switzerland
Phone +41 58 658 58 58
Fax +41 58 658 59 59
vCard


Practice Areas


 
 
 

 
 
 
 
 
 
 

Alex Nikitine Alex Nikitine Alex Nikitine Alex Nikitine

Alex Nikitine
Dr. iur., LL.M., Attorney at Law
Partner

Alex Nikitine's practice focuses on domestic and international M&A transactions, public tender offers, IPOs and other public (ECM/DCM) offerings, private equity and venture capital transactions, corporate governance and general corporate, stock exchange and capital markets laws. His experience for the last 15 years includes numerous transactions in these areas of expertise, in particular with companies in the Life Sciences, Banking or E-Commerce industry.

Alex Nikitine has been recommended by several international directories such as Chambers, IFLR1000 and The Legal 500 as a leading lawyer (by Chambers Global/Europe in both Corporate/M&A and Capital Markets). He is considered "knowledgeable and quick" and "very active and likeable" and is being appreciated by his "high level of client orientation" (The Legal 500; Chambers).

Alex Nikitine represents clients in proceedings before the SIX Swiss Exchange, the Swiss Takeover Board (UEK) and the Swiss financial market supervisory authority FINMA. He is a member of the board of examiners for the Swiss certified tax expert exams and a SIX Swiss Exchange recognised representative under art. 43 Listing Rules. He regularly publishes and speaks at conferences in his areas of expertise.

Alex Nikitine studied law at the University of Basel (lic. iur., 2000) and Harvard Law School (LL.M., 2004) and he received a doctorate (PhD; on Swiss and US securities laws) from the University of Zurich (Dr. iur., 2007). In 2009, he worked at Davis Polk & Wardwell LLP in New York, USA.

Alex Nikitine speaks German and English. He is registered with the Zurich Bar Registry and is admitted to practice in Switzerland as well as in the state of New York, USA.

 
 
 

 
 
 
 
 
 
 

Alex Nikitine
Direct phone: +41 58 658 56 32

Walder Wyss Ltd.
Seefeldstrasse 123
P.O. Box
8034 Zurich
Switzerland
Phone +41 58 658 58 58
Fax +41 58 658 59 59


vCard

Practice Areas Publications


Kommentar zum Finanzmarktinfrastrukturgesetz (FinfraG) (Commentary on the Financial Market Infrastructure Act (FMIA))

by Alex Nikitine and Sarah Schulthess
in: Sethe/Favre/Hess/Kramer/Schott (Editor[s]), "Kommentierung zu Art. 137–141 FinfraG (zum Übernahmerecht)"
Zurich 2017, pp. 1888–1935


Management Buy-out - Vorvertragliche Aufklärungspflichten der Manager (Management Buy-out - Pre-Contractual Disclosure Obligations of the Managers )

by Alex Nikitine
in: Rudolf Tschäni (Editor[s]), "Mergers & Acquisitions XVIII"
Zurich / Basel / Geneva 2016, pp. 239-277 (Sonderdruck aus Europa Institut Zürich, Band 169)





Kommentar zu Artikel 8-11, 30 VegüV(Commentary on articles 8-11, 30 VegüV)

by Alex Nikitine
in: Watter/Vogt (Editor[s]), "Basler Kommentar, Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften"
Basel 2015







Der unabhängige Stimmrechtsvertreter in der Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (VegüV): Überblick – herausgegriffene Fragen – Lösungsansätze(The independent shareholders' representative (unabhängiger Stimmrechtsvertreter) under the ordinance against excessive compensations at publicly listed corporations («VegüV»): Overview – Select Issues – Approach)

by Alex Nikitine
in: "Schweizerische Zeitschrift für Wirtschafts- und Finanzmarktrecht (SZW)" 5/2013, pp. 351–366










Use of Share Purchase Agreements in European Jurisdictions: Switzerland

co-authored by Micha Fankhauser and Alex Nikitine
in: Jaletzke/Henle/Beck (Editor[s]), "M&A Agreements in Germany"
Munich 2011, pp. 348–359




Die aktienrechtliche Organverantwortlichkeit nach Art. 754 Abs. 1 OR als Folge unternehmerischer Fehlentscheide: Konzeption und Ausgestaltung der «Business Judgment Rule» im Gefüge der Corporate Governance(The liability of the Board of Directors and Managers under Article 754 para. 1 CO for business judgements: Concept and structure of the business judgement rule in the Corporate Governance context)

by Alex Nikitine
Zurich 2007 (Dissertation)


Golden Handshakes, Golden Parachutes und ähnliche Vereinbarungen bei M&A-Transaktionen(Golden Handshakes, Golden Parachutes and similar arrangements in M&A transactions)

co-authored by Alex Nikitine
in: Rudolf Tschäni (Editor[s]), "Mergers & Acquisitions IX"
Zurich 2007 (Sonderdruck aus Europa Institut Zürich, Band 79)


Deals and Cases

IPO Medartis at SIX Swiss Exchange

Medartis Holding Ltd successfully listed its shares on the SIX Swiss Exchange. The proceeds from the IPO will be used for the expansion of international sales, for the development of the product portfolio and for acquisitions and other investments. The offer price was CHF 48 per share, implying a market capitalization of CHF 563 million. Zürcher Kantonalbank and Bryan Garnier & Co. act as the Joint Global Co-ordinators and Joint Bookrunners, Kepler Cheuvreux as Co-Manager. Quarton International is IPO advisor to Medartis.

Walder Wyss Ltd advises the underwriters on all legal aspects of the transaction. The team is led by Alex Nikitine (Partner, Capital Markets, Corporate/M&A) and Urs P. Gnos (Partner, Corporate/M&A) and also includes Fabian D. Glässer (Associate, Capital Markets, Corporate/M&A), Andreas Wildi (Partner, Life Sciences), Olivia Feusi (Associate, Corporate/M&A), Boris Räber (Associate, Corporate/M&A), Mirjam Olah (Associate, Corporate/M&A), Janine Corti (Counsel, Tax) and Carmen Spichiger (Trainee Lawyer, Corporate/M&A).


Swiss Auris Medical Holding AG (Nasdaq) implements Reverse Share Split through Intra-Group Merger

On March 12, 2018, the extraordinary general meeting of shareholders approved the merger of Auris Medical Holding AG, a Swiss company listed on Nasdaq, into Auris Medical NewCo Holding AG, a newly incorporated, wholly-owned Swiss Subsidiary. The Merger became effective on March 13, 2018, upon its registration in the Commercial Register in the Canton of Zug, Switzerland. Pursuant to the Merger, the shareholders of the transferring entity received 1 registered share with a nominal value of CHF 0.02 of the surviving company for every 10 old registered shares with a nominal value of CHF 0.40 each, effectively resulting in a “reverse share split” at a ratio of 10-for-1. The registered shares of the surviving company (renamed Auris Medical Holding AG) start trading on the Nasdaq Capital Market on March 14, 2018, under the trading symbol “EARS”. 

Walder Wyss has acted as legal counsel to Auris Medical. The team has been led by Alex Nikitine (Partner, M&A, Capital Markets) and further included Thiemo Sturny (Counsel, M&A, Capital Markets), Marion Bähler (Associate, M&A, Capital Markets), Vanessa C. Haubensak (Associate, M&A, Notary Services), Janine Corti (Counsel, Tax) and Michael Müller (Trainee, Corporate/M&A).


Tamedia pre-announces takeover of the media promoter Goldbach Group (SIX: GBMN)

On 22 December 2017, Tamedia pre-announced a public tender offer for all shares in Goldbach Group.

Walder Wyss advises Tamedia in connection with the public tender offer. The Walder Wyss team includes Urs Schenker (Counsel, Corporate/M&A), Markus Vischer (Partner, Corporate/M&A), Reto Jacobs (Partner, Antitrust & Competition), Daniel Dedeyan (Counsel, Banking & Finance) and Alex Nikitine (Partner, Corporate/M&A).


Metall Zug (SIX: METN) acquires majority holding in Haag-Streit Holding AG

The Metall Zug Group has signed an agreement to acquire 70% of Haag-Streit Holding AG, based in Köniz, Switzerland. The transaction is expected to be consummated during the first quarter of 2018. 

Haag-Streit is a leading medical technology company in the fields of ophthalmology (diagnostics & surgical microscopy), pulmonology and optics. The Haag-Streit Group comprises more than twenty companies in Europe, America and the Far East. Its head office is in Köniz, Switzerland, and it has additional production facilities in Switzerland, Germany, the United Kingdom and the USA. In the 2016 financial year the company and its approximately 900 employees generated sales of about CHF 200 million. As the Metall Zug Group’s fourth business unit, Haag-Streit will continue to maintain an independent market presence with its own autonomous brand. The Haag-Streit Group generated operating profit (EBITDA) of some CHF 30 million in the 2016 financial year. Its EBITDA margin was nearly 16%. 

Metall Zug, an industrial group of companies headquartered in Zug, comprises three Business Units and has a workforce of around 4,000. The holding company Metall Zug AG is listed in the Swiss Reporting Standard of SIX Swiss Exchange.

Walder Wyss Ltd has been advising Metall Zug as Lead Counsel on all legal aspects of the transaction. The Walder Wyss team is being led by Alex Nikitine (Partner, Corporate/M&A) and further includes Valentin Wiesner (Associate, Corporate/M&A), Hugh Reeves (Associate, IP/IT), Andreas Wildi (Partner, Life Sciences, Regulatory), André Kuhn (Associate, Real Estate), Lukas Wyss (Partner, Banking & Finance), Marion Bähler (Associate, Corporate/M&A), Fabian Looser (Associate, Employment), Annemarie Lagger (Associate, IP/IT) and Daniel Zimmerli (Managing Associate, Anti-Trust).


AMEOS Group acquires Swiss Hospital Seeklinik Brunnen

On 8 September 2017, the AMEOS Group acquired the Seeklinik Brunnen.

The Seeklinik Brunnen focuses on integrative medicine and specialises in the treatment of psychological disorders such as burnout, depression and sleep disorders. The clinic has 46 rooms and one of the most modern sleep laboratory in Switzerland.

Covering 41 locations in Germany, Austria and Switzerland, AMEOS Group has 12,800 employees working in 77 health care facilities. AMEOS Group is one of the most important health care providers in the German-speaking countries.

Walder Wyss AG advised AMEOS on all legal aspects of this transaction. The team has been led by Alex Nikitine (Partner, Corporate/M&A) and further included Fabian Glässer (Associate, Corporate/M&A), Francis Nordmann (Partner, Real Estate), André Kuhn (Associate, Real Estate), Daniel Staffelbach (Partner, Regulatory/Health Care) and Christoph Stutz (Associate, Labor law)


Curriculum Vitae PDF